Ypsomed Holding AG: certificati turbo CALL PUT Prodotti di Borsa e derivati | YPSN

Prodotti derivati

57.YcOB0KFxvNy68dn3bmt-XKeqcbYxTMvwzXc26QPEr8E.EqDZqsA7y7j1xauHJloKFf3-JPxBK4mGog51i2eHxZkvh-i4yRPblfGJmA

Mnemo	Tipo	Tipo di prodotto	Maturità	Elasticità	Leva	Parità	Quotazioni	Emittente
RMACUV CALL	CALL	Certificati Azionari e Obbl.ri	22/04/2025		-	0.678	103.6 101.9	Vontobel
WYPAPV CALL	CALL	Warrant Plain-Vanilla	20/06/2025	5.88x	-	50	0.38 0.34	Vontobel
WYPARV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	6.87x	-	50	0.29 0.25	Vontobel
WYPASV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	22.32x	-	50	0.026 0.002	Vontobel
WYPANV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	6.45x	-	50	0.375 0.335	Vontobel
WYPAQV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	17.65x	-	50	0.068 0.028	Vontobel
WYPAGV CALL	CALL	Warrant Plain-Vanilla	20/06/2025	5.13x	-	50	0.6 0.56	Vontobel
WYPALV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	6.03x	-	50	0.485 0.445	Vontobel
WYPAOV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	14.03x	-	50	0.142 0.102	Vontobel
RYPABV CALL	CALL	Certificati Azionari e Obbl.ri	12/03/2026		-	0.358	95.2 94.7	Vontobel
WYPAJV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	5.5x	-	50	0.63 0.59	Vontobel
WYPACV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	4.84x	-	50	0.84 0.8	Vontobel
WYPADV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	9.67x	-	50	0.44 0.4	Vontobel
WYPAHV CALL	CALL	Plain-Vanilla-Warrants	20/06/2025	3.99x	-	100	0.51 0.49	Vontobel
WYPAEV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	7.11x	-	50	0.73 0.69	Vontobel
WYPAIV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	4.16x	-	100	0.55 0.53	Vontobel
WYPAFV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	3.64x	-	100	0.69 0.67	Vontobel
WYPAKV CALL	CALL	Warrant Plain-Vanilla	20/06/2025	3.12x	-	100	0.78 0.76	Vontobel
RYPAAV CALL	CALL	Certificati Azionari e Obbl.ri	21/10/2024		-	0.249	101.3 100.8	Vontobel

Tempo differito Swiss Exchange Altri mercati azionari 17:30:02 17/05/2024			Variaz. 5gg	Var. 1 gen.
328,5 ^CHF	-1,50%		-1,05%	+8,42%

12/04	L'azienda di apparecchiature dentali Straumann nomina un nuovo presidente	MT
11/04	L'utile core del primo trimestre di Gerresheimer soddisfa il consenso	RE